Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Circulating microRNAs as novel biomarkers for diabetes mellitus.

Guay C, Regazzi R.

Nat Rev Endocrinol. 2013 Sep;9(9):513-21. doi: 10.1038/nrendo.2013.86. Epub 2013 Apr 30. Review.

PMID:
23629540
2.

Are extracellular microRNAs involved in type 2 diabetes and related pathologies?

Rome S.

Clin Biochem. 2013 Jul;46(10-11):937-45. doi: 10.1016/j.clinbiochem.2013.02.018. Epub 2013 Mar 13. Review.

PMID:
23499584
3.

Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction.

Guay C, Jacovetti C, Nesca V, Motterle A, Tugay K, Regazzi R.

Diabetes Obes Metab. 2012 Oct;14 Suppl 3:12-21. doi: 10.1111/j.1463-1326.2012.01654.x. Review.

PMID:
22928560
4.

microRNAs in Pancreatic β-Cell Physiology.

Özcan S.

Adv Exp Med Biol. 2015;887:101-17. doi: 10.1007/978-3-319-22380-3_6.

PMID:
26662988
5.

Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals.

Zhang T, Lv C, Li L, Chen S, Liu S, Wang C, Su B.

Biomed Res Int. 2013;2013:761617. doi: 10.1155/2013/761617. Epub 2013 Dec 25.

6.

Application of microRNAs in diabetes mellitus.

Chen H, Lan HY, Roukos DH, Cho WC.

J Endocrinol. 2014 Jul;222(1):R1-R10. doi: 10.1530/JOE-13-0544. Epub 2014 Apr 29. Review.

7.

Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus.

Rong Y, Bao W, Shan Z, Liu J, Yu X, Xia S, Gao H, Wang X, Yao P, Hu FB, Liu L.

PLoS One. 2013 Sep 2;8(9):e73272. doi: 10.1371/journal.pone.0073272. eCollection 2013.

8.

MicroRNAs and type 2 diabetes/obesity.

Dehwah MA, Xu A, Huang Q.

J Genet Genomics. 2012 Jan;39(1):11-8. doi: 10.1016/j.jgg.2011.11.007. Epub 2011 Dec 29. Review.

PMID:
22293113
9.

MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.

Karolina DS, Armugam A, Tavintharan S, Wong MT, Lim SC, Sum CF, Jeyaseelan K.

PLoS One. 2011;6(8):e22839. doi: 10.1371/journal.pone.0022839. Epub 2011 Aug 1. Erratum in: PLoS One. 2011;6(9). doi: 10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622.

10.

Circulating non-coding RNAs as biomarkers of beta cell death in diabetes.

Farr RJ, Joglekar MV, Taylor CJ, Hardikar AA.

Pediatr Endocrinol Rev. 2013 Sep;11(1):14-20. Review.

PMID:
24079075
11.

Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.

Nielsen LB, Wang C, Sørensen K, Bang-Berthelsen CH, Hansen L, Andersen ML, Hougaard P, Juul A, Zhang CY, Pociot F, Mortensen HB.

Exp Diabetes Res. 2012;2012:896362. doi: 10.1155/2012/896362. Epub 2012 Jul 5. Erratum in: Exp Diabetes Res. 2012;2012:672865.

12.

Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes.

Mirra P, Raciti GA, Nigro C, Fiory F, D'Esposito V, Formisano P, Beguinot F, Miele C.

Epigenomics. 2015;7(4):653-67. doi: 10.2217/epi.15.18. Review.

PMID:
26111035
13.

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.

Diabetes Res Clin Pract. 2002 Jan;55(1):65-85.

PMID:
11755481
14.

Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes.

Astorri E, Guglielmi C, Bombardieri M, Alessandri C, Buzzetti R, Maggi D, Valesini G, Pitzalis C, Pozzilli P.

Horm Metab Res. 2010 Dec;42(13):955-60. doi: 10.1055/s-0030-1267206. Epub 2010 Oct 22.

PMID:
20972946
15.

Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat.

Esguerra JL, Bolmeson C, Cilio CM, Eliasson L.

PLoS One. 2011 Apr 7;6(4):e18613. doi: 10.1371/journal.pone.0018613.

16.

Diabetes mellitus, a microRNA-related disease?

Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R.

Transl Res. 2011 Apr;157(4):253-64. doi: 10.1016/j.trsl.2011.01.009. Epub 2011 Feb 4. Review.

PMID:
21420036
17.

MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes.

Salas-Pérez F, Codner E, Valencia E, Pizarro C, Carrasco E, Pérez-Bravo F.

Immunobiology. 2013 May;218(5):733-7. doi: 10.1016/j.imbio.2012.08.276. Epub 2012 Aug 23.

PMID:
22999472
18.

Epigenetic phenomena linked to diabetic complications.

Pirola L, Balcerczyk A, Okabe J, El-Osta A.

Nat Rev Endocrinol. 2010 Dec;6(12):665-75. doi: 10.1038/nrendo.2010.188. Epub 2010 Nov 2. Review.

PMID:
21045787
19.

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.

Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, Pang Z, Guan Q, Gao L, Zhao J, Zhao L.

Acta Diabetol. 2011 Mar;48(1):61-9. doi: 10.1007/s00592-010-0226-0. Epub 2010 Sep 21.

PMID:
20857148
20.

Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals.

Zhang T, Li L, Shang Q, Lv C, Wang C, Su B.

Biochem Biophys Res Commun. 2015 Jul 17-24;463(1-2):60-3. doi: 10.1016/j.bbrc.2015.05.017. Epub 2015 May 15.

PMID:
25986735
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk